Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06720597 · ClinicalTrials.gov registry record · NA
EndoPAT Device for Endothelial Dysfunction in ED
A NA study of Endothelial Dysfunction and Erectile Dysfunction, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06720597 is a NA study of Endothelial Dysfunction and Erectile Dysfunction that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 120 participants, above the 90-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06720597, a NA study of Endothelial Dysfunction and Erectile Dysfunction, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy
Conditions Studied
Interventions
- DRUG Daily low-dose PDE5 inhibitor therapy
- DRUG Testosterone therapy as per clinical guidelines.
Study Locations (1)
California
- UCI Urology | Men's Health Center - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-13 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06720597
The ClinicalTrials.gov registry entry for NCT06720597 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 90-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (33% higher). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Daily low-dose PDE5 inhibitor therapy is the first listed.
NCT06720597 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06720597 about?
NCT06720597 is a clinical study titled "EndoPAT Device for Endothelial Dysfunction in ED". To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endo...
What is the current status of trial NCT06720597?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-08-13. Estimated completion is 2027-01.
What conditions does trial NCT06720597 study?
This clinical trial studies the following conditions: Endothelial Dysfunction, Erectile Dysfunction, Hypogonadism, Male.
What interventions are being tested in trial NCT06720597?
The interventions under investigation include: Daily low-dose PDE5 inhibitor therapy (DRUG), Testosterone therapy as per clinical guidelines. (DRUG).
Who is sponsoring clinical trial NCT06720597?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06720597 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endothelial Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
Sodium Lowering Vascular Effects Trial
RECRUITING · NA
-
NightWare and Cardiovascular Health in Veterans With PTSD
RECRUITING · NA
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
-
Microvascular Dysfunction in Obesity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.